Viewing Study NCT06816927


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2025-12-26 @ 4:17 AM
Study NCT ID: NCT06816927
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-29
First Post: 2024-12-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module